Zobrazeno 1 - 10
of 102
pro vyhledávání: '"Karl-Heinz Kurth"'
Autor:
Bas Israël, Michiel Sedelaar, Karl-Heinz Kurth, Ivo G. Schoots, Jelle O. Barentsz, Theo M. de Reijke, Joyce G. R. Bomers, Frans M.J. Debruyne, Jean-Paul A. van Basten, Jos Immerzeel
Publikováno v:
European Urology, 81, 110-117
European Urology, 81(1), 110-117. Elsevier
European Urology, 81, 1, pp. 110-117
European urology, 81(1), 110-117. Elsevier
European Urology, 81(1), 110-117. Elsevier
European Urology, 81, 1, pp. 110-117
European urology, 81(1), 110-117. Elsevier
Background Transperineal magnetic resonance imaging–transrectal ultrasound fusion guided biopsy (MFGB) is an increasingly popular technique due to increasing rates of biopsy-related infections. However, its widespread implementation has been hamper
Autor:
Richard Sylvester, Karl-Heinz Kurth
Publikováno v:
European Urology Supplements. 6:789-799
Objectives To summarize the most important clinical prognostic factors of non–muscle-invasive bladder cancer, as assessed by the European Organization for Research and Treatment of Cancer (EORTC) Genito-Urinary Group, to present biologic markers in
Publikováno v:
Urology, 69(4 Suppl), 5-8. Elsevier Inc.
As a result of variations in disease definition and diagnostic criteria for interstitial cystitis (IC), the performance of epidemiologic studies has been challenging. Initial prevalence studies used physician-confirmed diagnoses of IC; more recent st
Autor:
Reg R. Hall, Richard J. Sylvester, Karl Heinz Kurth, K.E.J. Landsoght, Maurizio Brausi, Paul Carpentier, Theo M. de Reijke, Kees van de Beek
Publikováno v:
Journal of urology, 173(2), 405-409. Elsevier Inc.
PURPOSE: We compared the efficacy and side effects of intravesical instillations of bacillus Calmette-Guerin (BCG) and epirubicin in patients with carcinoma in situ (CIS) of the bladder. MATERIALS AND METHODS: Patients with primary, secondary or conc
Publikováno v:
British Journal of Cancer
Intravesical instillation of Bacillus Calmette-Guérin (BCG) is used for the treatment of superficial bladder cancer, both to reduce the recurrence rate of bladder tumour and to diminish the risk of progression. Since its first therapeutic applicatio
Autor:
Karl Heinz Kurth, Peter P. Karthaus, Fritz H. Schröder, Laurence Collette, Wytze J. Hoekstra, Sophie D. Fosså, Muriel Debois
Publikováno v:
Journal of Urology, 172(3), 923-927. Elsevier Inc.
Journal of urology, 172(3), 923-927. Elsevier Inc.
Journal of urology, 172(3), 923-927. Elsevier Inc.
The timing of endocrine treatment for prostate cancer remains controversial. The issue is addressed in protocol 30846 of the European Organisation for Research and Treatment of Cancer for patients with lymph node positive cancer without local treatme
Autor:
Simon Horenblas, Adriaan Visser, Maarten C.C.M. Hulshof, Aeilko H. Zwinderman, G. van Andel, Karl-Heinz Kurth
Publikováno v:
Prostate, 58(4), 354-365. Wiley-Liss Inc.
BACKGROUND The objective of the present study is to compare the impact on the general and disease-specific health related quality of life (HRQOL) of external radiation therapy (ERT) with radical prostatectomy (RP) in patients with localized prostate
Publikováno v:
BJU International. 92:217-222
OBJECTIVE To assess whether baseline health-related quality of life (HRQOL) and psychosocial profiles differ in patients with prostate cancer scheduled for radical prostatectomy (RP) or external radiation therapy (ERT), as there is evidence that HRQO
Autor:
Adriaan Visser, Ary Dijkstra, Elsbeth Voogt, George van Andel, Patty Rovers, Karl Goodkin, Pim Willems, Karl-Heinz Kurth
Publikováno v:
Patient education and counseling, 49(3), 225-232. Elsevier Ireland Ltd
Patient Education and Counseling, 49(3):PII S0738-3991(02)00221-5, 225-232. ELSEVIER IRELAND LTD
Patient Education and Counseling, 49(3):PII S0738-3991(02)00221-5, 225-232. ELSEVIER IRELAND LTD
The objective of the pilot study is to measure the changes in health-related quality of life (HRQOL, general and prostate specific) 3 months after the disease has been diagnosed in men with prostate cancer. The results are compared with benign prosta
Autor:
Peter W. Hamilton, Giovanni Muzzonigro, Bernd J. Schmitz-Dräger, Andrea B. Galosi, Michael J. Droller, David M. Lubaroff, Burkhard Helpap, Karl Heinz Kurth, David J. Waters
Publikováno v:
Virchows Archiv. 442(4):309-316
An international consultation on the diagnosis of non-invasive urothelial neoplasms was held in Ancona, Italy in May 2001. Besides histology and problems of classification, one group of experts (Committee no. 3) discussed the molecular pathology and